News - Microbiology and Immunology

SIV's natural hosts can reveal how humans might better manage HIV Infection (03/08/2012)

Scientists discover effects of PD-1 blockade on antiretroviral therapy in SIV-infected monkeys (03/08/2012)

HIV/AIDS Vaccine Shows Long-Term Protection Against Multiple Exposures in Nonhuman Primates (03/07/2012)

SIV-Resistant Monkeys Close the Gates to Viral Infection (06/27/2011)

Yerkes Researcher Finds Virus-Mimicking Nanoparticles Can Stimulate Long Lasting Immunity (02/23/2011)

Rama Rao Amara, PhD, Featured on Emory Health Now Blog (12/20/2010)

Yerkes Research Sheds Light on Regulatory Cells in the Intestine (08/19/2010)

NIH Awards Emory $15.5 Million to Establish Center for Systems Vaccinology (08/13/2010)

New Insight Into Role Of T-Cells In HIV Infections Increases Understanding Of Immune System (08/05/2010)

Leading HIV Scientist to Join Yerkes as Georgia Research Alliance Eminent Scholar (04/13/2010)

Research Suggests a New Focus for AIDS Vaccine Strategies (02/09/2010)

Yerkes Researchers Propose Ambitious New Strategies For AIDS Vaccine Research (08/07/2009)

Yerkes Plays Vital Role In Unprecedented Study Challenging Prevailing View Of AIDS In Nonhuman Primates (07/30/2009)

Blocking Immune Inhibitor Improves Response to HIV-Like Virus, Prolongs Survival in Monkeys (12/15/2008)

Emory Researchers Discover Strategy For Predicting The Immunity Of Vaccines (11/25/2008)

New Clinical Trial Begins for HIV/AIDS Vaccine Developed at Emory, GeoVax, NIH and CDC (04/15/2006)

Neonatal Porcine Cells Offer Promise for Much-Needed Supply of Islet Cells for Human Diabetic Patients (02/26/2006)

Investigational Transplant Drug Preserves Kidneys While Avoiding Toxic Side Effects Common to Immunosuppressant Medications (02/21/2005)

Emory Researchers Discover Novel Mechanism of How Anthrax Impairs Immunity (07/16/2003)

AIDS Vaccine Developed at Emory University and the National Institutes of Health Moves to Clinical Trials (01/23/2003)